459 related articles for article (PubMed ID: 23223834)
1. Current status of co-occurring mood and substance use disorders: a new therapeutic target.
Pettinati HM; O'Brien CP; Dundon WD
Am J Psychiatry; 2013 Jan; 170(1):23-30. PubMed ID: 23223834
[TBL] [Abstract][Full Text] [Related]
2. [Co-occuring mood and substance use disorders].
Adida M; Kaladjian A; Fakra E; Belzeaux R; Azorin JM
Encephale; 2014 Dec; 40 Suppl 3():S8-S13. PubMed ID: 25550243
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone in patients with bipolar disorder and alcohol dependence.
Brown ES; Beard L; Dobbs L; Rush AJ
Depress Anxiety; 2006; 23(8):492-5. PubMed ID: 16841344
[TBL] [Abstract][Full Text] [Related]
4. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
Wobrock T; D'Amelio R; Falkai P
Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
[TBL] [Abstract][Full Text] [Related]
6. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and Co-occurring substance abuse or dependence.
Kemp DE; Gao K; Ganocy SJ; Elhaj O; Bilali SR; Conroy C; Findling RL; Calabrese JR
J Clin Psychiatry; 2009 Jan; 70(1):113-21. PubMed ID: 19192457
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Horsfall J; Cleary M; Hunt GE; Walter G
Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
[TBL] [Abstract][Full Text] [Related]
8. Major depression and comorbid substance use disorders.
Davis L; Uezato A; Newell JM; Frazier E
Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
[TBL] [Abstract][Full Text] [Related]
9. Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort.
Davis LL; Rush JA; Wisniewski SR; Rice K; Cassano P; Jewell ME; Biggs MM; Shores-Wilson K; Balasubramani GK; Husain MM; Quitkin FM; McGrath PJ
Compr Psychiatry; 2005; 46(2):81-9. PubMed ID: 15723023
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
[TBL] [Abstract][Full Text] [Related]
11. Mood disorders in the elderly.
Gebretsadik M; Jayaprabhu S; Grossberg GT
Med Clin North Am; 2006 Sep; 90(5):789-805. PubMed ID: 16962842
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone and disulfiram in patients with alcohol dependence and current depression.
Petrakis I; Ralevski E; Nich C; Levinson C; Carroll K; Poling J; Rounsaville B;
J Clin Psychopharmacol; 2007 Apr; 27(2):160-5. PubMed ID: 17414239
[TBL] [Abstract][Full Text] [Related]
13. Substance use and the treatment of resistant depression in adolescents.
Goldstein BI; Shamseddeen W; Spirito A; Emslie G; Clarke G; Wagner KD; Asarnow JR; Vitiello B; Ryan N; Birmaher B; Mayes T; Onorato M; Zelazny J; Brent DA
J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1182-92. PubMed ID: 19858762
[TBL] [Abstract][Full Text] [Related]
14. Management of comorbid bipolar disorder and substance abuse.
Vornik LA; Brown ES
J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.
Pettinati HM; Oslin DW; Kampman KM; Dundon WD; Xie H; Gallis TL; Dackis CA; O'Brien CP
Am J Psychiatry; 2010 Jun; 167(6):668-75. PubMed ID: 20231324
[TBL] [Abstract][Full Text] [Related]
16. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
Brunette MF; Noordsy DL; Xie H; Drake RE
Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of combined citalopram and naltrexone for nonabstinent outpatients with co-occurring alcohol dependence and major depression.
Adamson SJ; Sellman JD; Foulds JA; Frampton CM; Deering D; Dunn A; Berks J; Nixon L; Cape G
J Clin Psychopharmacol; 2015 Apr; 35(2):143-9. PubMed ID: 25679122
[TBL] [Abstract][Full Text] [Related]
18. Comparison of associated features and drug treatment between co-occurring unipolar and bipolar disorders in depressed eating disorder patients.
Tseng MM; Chang CH; Liao SC; Chen HC
BMC Psychiatry; 2017 Feb; 17(1):81. PubMed ID: 28241886
[TBL] [Abstract][Full Text] [Related]
19. Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorder.
Lieberman DZ; Kolodner G; Massey SH; Williams KP
J Addict Dis; 2009 Oct; 28(4):348-55. PubMed ID: 20155604
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients comorbid for addiction and other psychiatric disorders.
Brady KT; Verduin ML; Tolliver BK
Curr Psychiatry Rep; 2007 Oct; 9(5):374-80. PubMed ID: 17915076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
